Spirig received an exclusive license to use one of 3M's immune response modifier molecules to further develop a therapeutic to treat non-melanoma skin cancer

3M Co.

U.S. / Other

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Spirig Pharma AG

Switzerland / Private Biopharma

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced